Correlation between Subclinical Heart Disease and Cardiovascular Risk Profiles in an Urban Emergency Department

Heather M Prendergast1, Joseph Colla1, Neal Patel1

  • 1Department of Emergency Medicine, University of Illinois, Chicago, Illinois.

Insights

Uncontrolled hypertension significantly increases cardiovascular risks. This study found 39% of emergency department patients with elevated blood pressure had subclinical heart disease, indicating a need for early detection and intervention.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Hypertension Research

Background:

  • Uncontrolled hypertension is a major risk factor for cardiovascular complications.
  • Early identification of subclinical heart disease is crucial for managing hypertensive patients.

Purpose of the Study:

  • To determine the prevalence of left ventricular hypertrophy (LVH) and diastolic dysfunction in an urban emergency department (ED) population with elevated blood pressure (BP).
  • To explore correlations between subclinical heart disease and patient cardiovascular risk profiles.

Main Methods:

  • A convenience sample of patients with elevated BP (>140/90 mmHg) underwent limited bedside echocardiograms (LBE).
  • Subclinical hypertensive heart disease was defined by the presence of LVH, abnormal ejection fraction (EF), or diastolic dysfunction.

Main Results:

  • 39% of enrolled patients (n=39) exhibited subclinical heart disease.
  • Prevalence included 31% with LVH, 15% with diastolic dysfunction, and 8% with abnormal EF.
  • Elevated BP, blood urea nitrogen, and ED antihypertensive medication administration were associated with subclinical heart disease.

Conclusions:

  • A significant point prevalence (39%) of subclinical heart disease was identified in this urban ED population using LBE.
  • Real-time identification of subclinical heart disease and abnormal renal function in the ED can guide aggressive therapy and urgent follow-up.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
773
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
783
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
720
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
481